Tomasz Skirecki

2.3k total citations
45 papers, 744 citations indexed

About

Tomasz Skirecki is a scholar working on Immunology, Epidemiology and Molecular Biology. According to data from OpenAlex, Tomasz Skirecki has authored 45 papers receiving a total of 744 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Immunology, 16 papers in Epidemiology and 14 papers in Molecular Biology. Recurrent topics in Tomasz Skirecki's work include Sepsis Diagnosis and Treatment (14 papers), Immune Response and Inflammation (12 papers) and Inflammasome and immune disorders (10 papers). Tomasz Skirecki is often cited by papers focused on Sepsis Diagnosis and Treatment (14 papers), Immune Response and Inflammation (12 papers) and Inflammasome and immune disorders (10 papers). Tomasz Skirecki collaborates with scholars based in Poland, Germany and France. Tomasz Skirecki's co-authors include Jean‐Marc Cavaillon, Mervyn Singer, Grażyna Hoser, J Kawiak, Joanna Domagała‐Kulawik, Jarosław Czubak, Piotr Bielicki, Zygmunt Pojda, Marcin F. Osuchowski and Małgorzata Mikaszewska-Sokolewicz and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Scientific Reports.

In The Last Decade

Tomasz Skirecki

43 papers receiving 739 citations

Peers

Countries citing papers authored by Tomasz Skirecki

Since Specialization

Citations

This map shows the geographic impact of Tomasz Skirecki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomasz Skirecki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomasz Skirecki more than expected).

Fields of papers citing papers by Tomasz Skirecki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomasz Skirecki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomasz Skirecki. The network helps show where Tomasz Skirecki may publish in the future.

Co-authorship network of co-authors of Tomasz Skirecki

This figure shows the co-authorship network connecting the top 25 collaborators of Tomasz Skirecki. A scholar is included among the top collaborators of Tomasz Skirecki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomasz Skirecki. Tomasz Skirecki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Age-related STING suppression in macrophages contributes to increased viral load during influenza a virus infection 2024 ·Immunity & Ageing ·(unknown), Antje Häder, (unknown), (unknown), Sándor Nietzsche, (unknown), (unknown), (unknown), Sascha Brunke, Torsten Doenst, Tomasz Skirecki, Bettina Löffler, Stefanie Deinhardt‐Emmer	1
2	CD71⁺ erythroid cells promote multiple myeloma progression and impair anti‐bacterial immune response 2024 ·British Journal of Haematology ·(unknown), Tomasz M. Grzywa, (unknown), Zofia Pilch, (unknown), Grażyna Hoser, Olga Gewartowska, (unknown), Joanna Barankiewicz, (unknown), Olga Ciepiela, Przemysław Juszczyński, Aleksander Owczarek, Michał Węgrzynowicz, Tomasz Skirecki, (unknown), Dominika Nowis	1
3	Nod-like receptors: The relevant elements of glioblastoma`s prognostic puzzle 2024 ·Pharmacological Research ·(unknown), Michał Sobstyl, Tomasz Skirecki	3
4	Compartmentalization of the inflammatory response during bacterial sepsis and severe COVID-19 2024 ·SHILAP Revista de lepidopterología ·Jean‐Marc Cavaillon, Benjamin G. Chousterman, Tomasz Skirecki	0
5	SARS-CoV-2 and its ORF3a, E and M viroporins activate inflammasome in human macrophages and induce of IL-1α in pulmonary epithelial and endothelial cells 2024 ·Cell Death Discovery ·(unknown), Piotr Kozłowski, Grażyna Hoser, (unknown), (unknown), Dominika Nowis, Jakub Gołąb, (unknown), Agnieszka Piekiełko‐Witkowska, (unknown), (unknown), Stefanie Deinhardt‐Emmer, Ewa Kozłowska, Tomasz Skirecki	11
6	The Role of Pericytes in Lipopolysaccharide-Induced Murine Acute Respiratory Distress Syndrome 2024 ·American Journal Of Pathology ·(unknown), (unknown), Władysława Stremińska, (unknown), (unknown), Grażyna Hoser, (unknown), Magdalena Gewartowska, Małgorzata Frontczak‐Baniewicz, Maria A. Ciemerych, Edyta Brzóska, Tomasz Skirecki	2
7	Anti-inflammatory and antioxidant actions of extracts from Rheum rhaponticum and Rheum rhabarbarum in human blood plasma and cells in vitro 2023 ·Biomedicine & Pharmacotherapy ·(unknown), (unknown), Tomasz Skirecki, Justyna Krzyżanowska‐Kowalczyk, Mariusz Kowalczyk, Joanna Kołodziejczyk-Czepas	14
8	A Bittersweet Kiss of Gram-Negative Bacteria: The Role of ADP-Heptose in the Pathogenesis of Infection 2023 ·Microorganisms ·(unknown), Tomasz Skirecki	6
9	Inflammasome-related Markers upon ICU Admission do not Correlate with Outcome in Critically Ill COVID-19 Patients 2022 ·Shock ·Barbara Adamik, (unknown), (unknown), (unknown), (unknown), Waldemar Goździk, Tomasz Skirecki	6
10	Renaissance of glucocorticoids in critical care in the era of COVID-19: ten urging questions 2022 ·Critical Care ·Martin Sebastian Winkler, Marcin F. Osuchowski, Didier Payen, Antoni Torres, (unknown), Tomasz Skirecki	7
11	Hearing Loss as the Main Clinical Presentation in NLRP3-Associated Autoinflammatory Disease 2022 ·Frontiers in Immunology ·(unknown), (unknown), (unknown), (unknown), Tomasz Skirecki, Ewa Więsik–Szewczyk, Mariusz Furmanek, (unknown), Henryk Skarżyńśki, Monika Ołdak	9
12	An Early Myelosuppression in the Acute Mouse Sepsis Is Partly Outcome-Dependent 2021 ·Frontiers in Immunology ·Tomasz Skirecki, Susanne Drechsler, (unknown), Grażyna Hoser, Mohammad Jafarmadar, J Kawiak, Marcin F. Osuchowski	8
13	Bone marrow is the preferred site of memory CD4+ T cell proliferation during recovery from sepsis 2020 ·JCI Insight ·Tomasz Skirecki, (unknown), Grażyna Hoser, Jakub Gołąb, Dominika Nowis, Ewa Kozłowska	18
14	Immunophenotype of T Cells Expressing Programmed Death-1 and Cytotoxic T Cell Antigen-4 in Early Lung Cancer: Local vs. Systemic Immune Response 2019 ·Cancers ·Iwona Kwiecień, Tomasz Skirecki, (unknown), (unknown), Joanna Domagała‐Kulawik	17
15	Mobilization of Stem and Progenitor Cells in Septic Shock Patients 2019 ·Scientific Reports ·Tomasz Skirecki, Małgorzata Mikaszewska-Sokolewicz, Marlena Godlewska, Barbara Dołęgowska, Jarosław Czubak, Grażyna Hoser, J Kawiak, (unknown)	20
16	T, B, and NKT Cells in Systemic Inflammation in Obstructive Sleep Apnoea 2015 ·Mediators of Inflammation ·Joanna Domagała‐Kulawik, Iwona Osińska, (unknown), Piotr Bielicki, Tomasz Skirecki	32
17	Procalcitonin in early onset ventilator-associated pneumonia 2012 ·Journal of Hospital Infection ·(unknown), Tomasz Skirecki, (unknown), Barbara Czarnocka	17
18	Absolute counts of peripheral blood leukocyte subpopulations in intraabdominal sepsis and pneumonia-derived sepsis: a pilot study 2012 ·Folia Histochemica et Cytobiologica ·Grażyna Hoser, Tomasz Skirecki, (unknown), (unknown), J Kawiak	16
19	Bronchoalveolar Lavage Total Cell Count in Interstitial Lung Diseases—Does It Matter? 2011 ·Inflammation ·Joanna Domagała‐Kulawik, Tomasz Skirecki, Marta Maskey‐Warzęchowska, H Grubek-Jaworska, Ryszarda Chazan	24
20	Characterization of a new small cell lung cancer (SCLC) cell line STP54 derived from a metastatic bioptate of a combined type of SCLC with Non-SCLC component. 2009 ·Folia Histochemica et Cytobiologica ·Tomasz Skirecki, Grażyna Hoser, Joanna Domagała‐Kulawik, J Kawiak	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact